Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -7.624M
June 30, 2026 -14.56M
March 31, 2026 -8.681M
December 31, 2025 -13.03M
September 30, 2025 -9.693M
June 30, 2025 -8.828M
March 31, 2025 -4.577M
December 31, 2024 -3.343M
September 30, 2024 -17.46M
June 30, 2024 -2.254M
March 31, 2024 -3.668M
December 31, 2023 -6.770M
September 30, 2023 -5.875M
Date Value
June 30, 2023 -5.011M
March 31, 2023 -6.308M
December 31, 2022 -3.557M
September 30, 2022 -3.854M
June 30, 2022 -3.986M
March 31, 2022 -3.438M
December 31, 2021 -3.092M
September 30, 2021 -1.443M
June 30, 2021 -5.030M
March 31, 2021 -0.892M
September 30, 2020 -0.8762M
June 30, 2020 7.479M
March 31, 2020 0.8265M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. -95.61M
Neumora Therapeutics, Inc. -34.44M
LENZ Therapeutics, Inc. -30.97M
ANI Pharmaceuticals, Inc. 32.72M
Corcept Therapeutics, Inc. 124.49M

Net Income (Quarterly) Related Metrics